The results demonstrated that TBL1X expression was significantly different in 13 types of tumors compared to their relative normal tissues, with higher expression of TBL1X in six types of cancers, including HNSC, and lower expression in the other seven types of tumor tissues (Figure 1A). This evidence concerns the gene TBL1X and neoplasm.